||GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and ...
||LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM...
||LJH685 is an effective pan-RSK inhibitor for RSK1/2/3 (IC50: 6/5/4 nM).
||BI-D1870 is a specific, ATP-competitive inhibitor of RSK isoforms, with IC50 values o...
||LY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. Phase 1...
||CHIR 98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free a...
||AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/...
||PI3K-IN-2 is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, ...
||PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) .I...
||AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTO...
||LY2584702 Tosylate is a selective, ATP-competitive p70S6K inhibitor, used in trials s...